级联报告:支持抗菌药物管理的工具还是危险误导?
本文以点-反点形式讨论抗菌药物敏感性试验(AST)级联报告。级联报告指当窄谱一线药物体外敏感时抑制宽谱药物报告,研究显示可减少宽谱抗菌药物使用并降低耐药率,但实施复杂且对长期处方行为影响存疑。专家共识认为级联报告有益于抗菌药物管理,但需谨慎实施方案以降低对患者和公共卫生的风险。
要点
- 级联报告在窄谱药物敏感时抑制宽谱药物报告,可减少宽谱抗菌药物使用。
- 实施级联报告复杂,对长期处方行为的影响存在疑问。
- 专家共识认为级联报告有益于抗菌药物管理,但需谨慎实施以降低风险。
核心结论
- 专家共识认为级联报告有益于抗菌药物管理,但方案需谨慎实施以最小化对患者和公共卫生的风险。
研究设计与样本
- 本文为点-反点(Point-Counterpoint)形式,由专家对AST级联报告的益处与风险进行讨论。
主要发现
- 研究表明级联报告可减少宽谱抗菌药物使用并降低抗菌药物耐药率。
- 实施级联报告可能复杂,且有人质疑其对长期处方行为的影响。
- 存在对依从性以及可能对抗菌药物耐药公共卫生监测产生负面影响的担忧。
关键数值与推荐
- 级联报告指当窄谱一线抗菌药物显示体外敏感时,抑制宽谱抗菌药物的报告。
临床怎么用
- 临床实验室可采用级联报告作为抗菌药物管理策略,引导临床医生使用更窄谱抗菌药物。
- 实施级联报告需谨慎设计方案,以降低对患者和公共卫生监测的风险。
局限性
- 原文未报告具体研究数据、样本量或统计值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Addressing antimicrobial resistance requires multi-disciplinary action, including from the clinical laboratory. Cascade reporting of the antimicrobial susceptibility test (AST) is a strategy used by some laboratories to nudge clinicians toward the use of more narrow-spectrum antimicrobials. Cascade reporting involves suppression of broader-spectrum antimicrobials if the narrower-spectrum first-line antimicrobials show in-vitro susceptibility. Studies have shown that cascade reporting can reduce use of broad-spectrum antimicrobials and reduce antimicrobial resistance rates. However, implementing cascade reporting can be complex, and some question the effectiveness on impacting long-term prescribing behaviors. Furthermore, there are concerns surrounding compliance and the possible negative impact on public health surveillance for antimicrobial resistance. In this article, experts weigh in on the benefits and risks associated with implementing AST cascade reporting. General consensus is that cascade reporting is a benefit to antimicrobial stewardship, but protocols need careful implementation to minimize risk to patients and public health.
引用
- Kuti JL, Lutgring JD, Simner PJ, et al. Point-Counterpoint: Cascade reporting-useful tool to support antimicrobial stewardship, or dangerously misleading. J Clin Microbiol. 2025. PMID: 40526395. doi:10.1128/jcm.01708-24
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。